
Conventional drug discovery strategies are typically zzso zzso based on the selection of lead compounds with zzso zzso potency and selectivity zzso However, zzso rates are often the result of zzso or redundant cancer mechanisms and the fact that zzso do not find it difficult to escape zzso of a single zzso In this article, we highlight two emerging and complimentary zzso namely zzso imaging and zzso zzso zzso which when combined with relevant disease models can provide zzso and drug combination strategies that predict and counteract inherent and zzso drug zzso The zzso of such approaches at early stages of the drug discovery process enables more informed decisions on candidate drug selection and how to zzso and predict efficacy before clinical zzso 

